Interleukin-12 and interleukin-27 regulate macrophage control of Mycobacterium tuberculosis

被引:84
作者
Robinson, Cory M. [1 ]
Nau, Gerard J. [1 ,2 ,3 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Sch Med, Dept Med, Div Infect Dis, Pittsburgh, PA 15261 USA
[3] Univ Pittsburgh, Sch Med, Ctr Vaccine Res, Pittsburgh, PA 15261 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1086/589774
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mycobacterium tuberculosis is an intracellular pathogen that persists within macrophages and remains a considerable global threat to human health. The purpose of this study was to investigate how interleukin (IL)-12 and IL-27 regulate human macrophage interactions with M. tuberculosis. Quantitative measurement of transcripts showed that IL-12 or M. tuberculosis induced IL-27 gene expression in human macrophages. Furthermore, IL-27 receptor subunits were shown by reverse transcription-polymerase chain reaction and flow cytometry to be expressed and present at the cell surface. Neutralization of IL-27 in the presence of IL-12 reduced viable M. tuberculosis recovered from macrophages. Antimycobacterial activity was accompanied by a heightened inflammatory response that included tumor necrosis factor, IL-6, interferon-gamma, and a subset of chemokines. These results implicate IL-12 and IL-27 in regulating human macrophages, and IL-27 derived from macrophages during infection impedes control of M. tuberculosis growth.
引用
收藏
页码:359 / 366
页数:8
相关论文
共 42 条
  • [1] Chemokines and tuberculosis
    Algood, HMS
    Chan, J
    Flynn, JL
    [J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2003, 14 (06) : 467 - 477
  • [2] Bean AGD, 1999, J IMMUNOL, V162, P3504
  • [3] Modulation of virulence factors in Francisella tularensis determines human macrophage responses
    Carlson, Paul E., Jr.
    Carroll, James A.
    O'Dee, Dawn M.
    Nau, Gerard J.
    [J]. MICROBIAL PATHOGENESIS, 2007, 42 (5-6) : 204 - 214
  • [4] The human model: A genetic dissection of immunity to infection in natural conditions
    Casanova, JL
    Abel, L
    [J]. NATURE REVIEWS IMMUNOLOGY, 2004, 4 (01) : 55 - 66
  • [5] KILLING OF VIRULENT MYCOBACTERIUM-TUBERCULOSIS BY REACTIVE NITROGEN INTERMEDIATES PRODUCED BY ACTIVATED MURINE MACROPHAGES
    CHAN, J
    XING, Y
    MAGLIOZZO, RS
    BLOOM, BR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (04) : 1111 - 1122
  • [6] Development of Th1-type immune responses requires the type I cytokine receptor TCCR
    Chen, Q
    Ghilardi, N
    Wang, H
    Baker, T
    Xie, MH
    Gurney, A
    Grewal, IS
    de Sauvage, FJ
    [J]. NATURE, 2000, 407 (6806) : 916 - 920
  • [7] Interferon-inducible T cell alpha chemoattractant (I-TAC): A novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3
    Cole, KE
    Strick, CA
    Paradis, TJ
    Ogborne, KT
    Loetscher, M
    Gladue, RP
    Lin, W
    Boyd, JG
    Moser, B
    Wood, DE
    Sahagan, BG
    Neote, K
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (12) : 2009 - 2021
  • [8] DISSEMINATED TUBERCULOSIS IN INTERFERON-GAMMA GENE-DISRUPTED MICE
    COOPER, AM
    DALTON, DK
    STEWART, TA
    GRIFFIN, JP
    RUSSELL, DG
    ORME, IM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) : 2243 - 2247
  • [9] COOPER AM, 1995, IMMUNOLOGY, V84, P423
  • [10] Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis
    Cooper, AM
    Magram, J
    Ferrante, J
    Orme, IM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (01) : 39 - 45